Us Congress 2025-2026 Regular Session

Us Congress House Bill HB91

Introduced
1/3/25  

Caption

Freedom for Farmers Act of 2025This bill abolishes the Agency for Toxic Substances and Disease Registry. Currently, this agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. The bill requires HHS to transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.

Impact

The abolishment of the ATSDR is expected to have significant implications for how toxic substances and related health concerns are monitored and addressed at the federal level. By transferring the authority to HHS, the bill aims to centralize functions, which proponents argue will enhance efficiency. However, critics express concern that this transition could lead to diminished oversight and reduced focus on the unique health risks posed by toxic substances, adversely impacting environmental health initiatives that the ATSDR currently oversees. The national registry of individuals exposed to toxic substances and serious illnesses is suggested to be at risk, potentially leading to gaps in data critical for public health policymaking.

Summary

House Bill 91 seeks to abolish the Agency for Toxic Substances and Disease Registry (ATSDR), which is responsible for evaluating and reporting on the impact of toxic substances on public health and maintaining national registries for serious diseases and exposures. The bill proposes that all functions of the ATSDR would terminate one year after enactment, transferring its critical responsibilities to the Department of Health and Human Services (HHS). This move is positioned as a means to streamline governmental functions, potentially consolidating resources and authority within existing federal health structures.

Contention

The proposal has generated debate, as various stakeholders weigh the benefits of administrative efficiency against potential risks to public health monitoring and response. Supporters contend that the elimination of the ATSDR is a logical step to consolidate functions and improve the effectiveness of federal health agencies. They argue that HHS is better positioned to manage these responsibilities. Conversely, opponents of the bill fear that the loss of a dedicated agency focused on toxic substance exposure could result in less rigorous public health surveillance and a weaker response capability regarding environmental health crises.

Congress_id

119-HR-91

Policy_area

Health

Introduced_date

2025-01-03

Companion Bills

No companion bills found.

Similar Bills

UT HB0524

Non-nicotine Inhalation Product Amendments

MN SF2371

Medical cannabis provisions modification

TX SB79

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and testing facilities; authorizing fees.

TX HB2107

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.

TX SB269

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and testing facilities; authorizing fees.

MN HF1672

Medical cannabis provisions modified.

TX HB4045

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by patients with certain eligible medical conditions and the licensing of dispensing organizations; changing a fee.

TX SB339

Relating to the medical use of low-THC cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense low-THC cannabis and any employee of a dispensing organization to obtain a registration; authorizing fees.